PRKCB and diabetes mellitus: These data indicate that PKCβ and PKCδ contribute to diabetes-accelerated atherosclerosis with the involvement of hepatic cholesterol metabolism, endothelial dysfunction, vascular inflammation, and monocyte recruitment and adhesion.